Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-16

Clinical Trial Update: Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects. [Phase 1]

View source ↗

Summary

A completed Phase 1 bioequivalence study comparing two 20 mg vonoprazan fumarate tablets (Vonopzan and Vocinti) in healthy adult subjects, in the context of gas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vocinti Tablet 20mg (vonoprazan fumarate)
  • Vonopzan Tablet 20mg (vonoprazan fumarate)

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Gastric Ulcer | Phase 1 | Status: COMPLETED